Eurican P

Introduction

Company name: Merial Animal Health Ltd

Address: PO Box 327

Sandringham House

Harlow Business Park

Harlow

Essex CM19 5TG

Telephone: Companion Animals 0870 6000123

Production Animals 0800 592699

Fax: 01279 775888

Email: ukenquiry@merial.com

Website: www.merial.com

Presentation

A live attenuated canine parvovirus vaccine presented as a buff coloured freeze-dried pellet.

Uses

For the active immunisation of dogs from 8 weeks of age to prevent clinical signs, and to reduce mortality and viral excretion caused by canine parvovirus infection.

Onset of immunity: 7 days after primary vaccination.

Duration of immunity: 2 years.

Dosage and administration

Reconstitute EURICAN P using EURICAN L or sterile water for injections where this product is available, immediately before use. Apply usual aseptic procedures and inject by the subcutaneous route.

It is well documented that high levels of maternally derived antibodies can interfere with an active immune response to vaccination. Ideally pups should be vaccinated as soon as maternally derived antibody has declined to a level at which the pup is susceptible. Under most practical circumstances this is not known and therefore the following regime is recommended.

For dogs and puppies from 8 weeks of age inject a 1 ml dose according to the following schedule:

Basic vaccination:

Puppies less than 12 weeks old:

First vaccination: from 8 weeks of age

Second vaccination: 3 to 5 weeks later from 12 weeks of age.

In puppies over 12 weeks of age a single injection is sufficient to confer immunity.

Revaccination:

One injection of EURICAN P every two years.

Contra-indications, warnings, etc

For animal treatment only.

The CPV vaccine strain of EURICAN P may be shed from vaccinated animals for a number of days following vaccination. However, due to the absence of pathogenicity of the strain, it is not necessary to keep vaccinated animals separated from non-vaccinated animals.

In rare cases, slight and transient pain may be apparent at the time of injection, which regresses within 2 hours. In exceptional circumstances a hypersensitivity reaction may occur which may require appropriate symptomatic treatment.

Can be used during pregnancy. In the absence of data from studies in seronegative bitches, EURICAN P should only be used in pregnant bitches which have previously been vaccinated before pregnancy.

No information is available on the safety and efficacy from the concurrent use of this vaccine with any other except EURICAN L. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with EURICAN P.

Do not mix with any other medicinal product except EURICAN L.

In case of accidental self-injection, seek medical advice immediately and show this package insert or the label to the physician.

Pharmaceutical precautions

Store and transport at +2°C to +8°C protected from light. Do not freeze.

Use immediately after reconstitution.

Keep out of the reach and sight of children.

Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.

Legal category

POM-V

Packaging Quantities

Packs containing 10 single dose vials.

Further information

Following the administration of overdoses of vaccine, slight and transient pain and oedema appear which regresses within 1 day.

Marketing authorisation number

Vm 08327/4151.